By Forrest Munden
EMT Tutor Podcast · ALS · 22:20
Show notes
This podcast is written by Forrest Munden and sponsored by Munden Interactive. I train paramedics and EMTs to pass the National Registry. A deep dive into the two most common sustained irregular rhythms — atrial fibrillation and atrial flutter — covering the mechanism behind each, the medications used to treat them, the complications, and how ALS manages a symptomatic patient.
Why the two rhythms are different
Fibrillation is chaotic atrial depolarisation at 350 to 600 times a minute, so there is no organised contraction and no P wave, and the ventricular response is irregularly irregular. Flutter is one organised reentrant circuit, classically travelling through the cavotricuspid isthmus, circling near 300 times a minute and producing sawtooth flutter waves with AV block that is usually 2:1. That is why a regular narrow-complex tachycardia at almost exactly 150 should be treated as atrial flutter with 2:1 block until proven otherwise — a resting adult at 150 with sinus tachycardia should make you doubt the diagnosis. Variable block makes flutter irregular, and the two rhythms convert into each other.
Why it matters — clots and stroke
Losing organised atrial contraction costs atrial kick and cardiac output, and blood stagnates in the left atrial appendage, a blind pouch where clots form. That is the mechanism behind embolic stroke. Atrial flutter carries stroke risk comparable to fibrillation, which is why it is anticoagulated on the same principles. A fast ventricular rate also drives ischaemic chest pain, decompensated heart failure, and tachycardia-induced cardiomyopathy — a reversible cause of a weak heart once the rate is controlled.
The medications
Diltiazem (Cardizem) is the workhorse for rate control. A non-dihydropyridine calcium channel blocker, it slows AV nodal conduction: 0.25 mg/kg actual body weight, typically about 20 mg, IV over two minutes, maximum bolus 20 mg. If the rate is still above 100 after 15 minutes, a second bolus of 0.35 mg/kg, maximum 25 mg, then an infusion starting near 5 mg/hr titrating to 15 mg/hr. The contraindications matter as much as the dose — hypotension, significant systolic heart failure because it is a negative inotrope, second or third degree AV block, and Wolff-Parkinson-White, where AV nodal blockade can send conduction down the accessory pathway and make the ventricular rate dangerously fast.
Beta blockers are the alternative, with metoprolol as the example: 2.5 to 5 mg IV over about two minutes, repeated up to three doses to roughly 15 mg, watching pressure and rate. Avoid them in decompensated heart failure and bronchospasm. The 2025 AHA tachycardia algorithm simply offers a beta blocker or a calcium channel blocker for the stable patient — so a clinician needs both, not a favourite.
Digoxin slows the AV node through increased vagal tone, but onset is measured in hours, so it is not the drug for a crashing patient. It is most useful as an add-on in heart failure or when a hypotensive patient will not tolerate the other agents. The loading regimen is a total digitalising dose of 8 to 12 micrograms per kg IV, half up front and the rest in quarter fractions every six to eight hours, with toxicity watched for — nausea, visual disturbance, confusion, bradyarrhythmia or ectopy, worse with renal impairment and low potassium.
Anticoagulation is the part that changes lives. Stroke risk is estimated with a validated score such as CHA2DS2-VASc and weighed against bleeding risk. Warfarin works by blocking vitamin K dependent clotting factors and needs titration to an INR target of 2.0 to 3.0. The direct oral anticoagulants — apixaban, rivaroxaban, edoxaban and dabigatran — need no routine INR monitoring and have fewer food interactions, but reversal is not simple and renal function affects them. Apixaban and rivaroxaban are factor Xa inhibitors; dabigatran is a direct thrombin inhibitor. Aspirin is not a substitute for anticoagulation in atrial fibrillation, and a held or missed dose is important history.
ALS care when the patient is symptomatic
The branch point is stability, not rate. Hypotension, acutely altered mental status, signs of shock, ischaemic chest discomfort or acute heart failure sends you to synchronised cardioversion, sedating whenever feasible, using your device’s recommended energy or the maximum if it is unknown. The 2025 figures are 200 J for atrial fibrillation, 200 J for atrial flutter, 100 J for narrow-complex tachycardia and 100 J for monomorphic ventricular tachycardia — reassess and escalate after each shock. Stable patients get rate control, treatment of the underlying cause and expert consultation.
Two safety points: adenosine does not convert atrial fibrillation and belongs to regular rhythms, and cardioverting a stable patient in fibrillation of unknown or prolonged duration can embolise clot, which is why duration and anticoagulation status belong to medical direction.
Study material and review questions are at EMS Notes, the study guide written by Forrest Munden. Education only, not medical direction; follow your local protocols and medical direction.
Leave a Reply